SCHEMBL14009929

SCHEMBL14009929

CCCCN1C(=O)OC(C)(C)C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
ELANE P08246 2/20 0.49
PRTN3 P24158 2/20 0.49
CTSG P08311 1/20 0.49
PTGS1 P23219 3/20 0.37
PTGS2 P35354 3/20 0.37
MGLL Q99685 2/20 0.37
FAAH O00519 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CNR1 P21554 4/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
ALOX12 P18054 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14009928 0.88 LMNA (0.54) LMNAELANEPRTN3CTSGKDM4E
SCHEMBL5005434 0.83 ELANE (0.51) LMNAELANEPRTN3CTSGSMN1; SMN2
Ethadione SCHEMBL35279 0.79 ELANE (0.55) LMNAELANEPRTN3CTSGMGLL
SCHEMBL13188868 0.78 LMNA (0.52) LMNAELANEPRTN3CTSGALDH1A1
SCHEMBL5006337 0.78 ELANE (0.54) LMNAELANEPRTN3CTSGALDH1A1
SCHEMBL4756222 0.78 LMNA (0.52) LMNAELANEPRTN3CTSGALDH1A1
Hydrochloric Acid SCHEMBL3149437 0.77 LMNA (0.50) LMNAELANEPRTN3CTSGALDH1A1
Ethadione SCHEMBL13724326 0.76 LMNA (0.70) LMNAELANEPRTN3CTSGMGLL
SCHEMBL4757604 0.76 LMNA (0.48) LMNAELANEPRTN3CTSG
SCHEMBL14009934 0.74 LMNA (0.47) LMNAELANEPRTN3CTSG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180194732-A1 MULTI-API LOADING PRODRUGS JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2018-07-12 US disclosed
US-20080275085-A1 Piperidine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 US disclosed
US-20080275085-A1 Piperidine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275085-A1 Piperidine derivative and use thereof TACR2, TACR1, PRLHR LMNA 4742/4885ELANE 4068/4885PRTN3 1621/4885
US-20180194732-A1 MULTI-API LOADING PRODRUGS AADAC, PAICS, ABCG2 LMNA 2855/4885ELANE 550/4885PRTN3 4122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.